Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network

Philip Johnson, Brian C. Samuels, Stephanie D. Fitz, Lauren M. Federici, Nathan Hammes, Maureen C. Early, William Truitt, Christopher A. Lowry, Anantha Shekhar

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: Although the hypothalamic orexin system is known to regulate appetitive behaviors and promote wakefulness and arousal (Sakurai, 2007 [56]), this system may also be important in adaptive and pathological anxiety/stress responses (Suzuki et al., 2005 [4]). In a recent study, we demonstrated that CSF orexin levels were significantly higher in patients experiencing panic attacks compared to non-panicking depressed subjects (Johnson et al., 2010 [9]). Furthermore, genetically silencing orexin synthesis or blocking orexin 1 receptors attenuated lactate-induced panic in an animal model of panic disorder. Therefore, in the present study, we tested if orexin (ORX) modulates panic responses and brain pathways activated by two different panicogenic drugs. Methods: We conducted a series of pharmacological, behavioral, physiological and immunohistochemical experiments to study the modulation by the orexinergic inputs of anxiety behaviors, autonomic responses, and activation of brain pathways elicited by systemic injections of anxiogenic/panicogenic drugs in rats. Results: We show that systemic injections of two different anxiogenic/panicogenic drugs (FG-7142, an inverse agonist at the benzodiazepine site of the GABAA receptor, and caffeine, a nonselective competitive adenosine receptor antagonist) increased c-Fos induction in a specific subset of orexin neurons located in the dorsomedial/perifornical (DMH/PeF) but not the lateral hypothalamus. Pretreating rats with an orexin 1 receptor antagonist attenuated the FG-7142-induced anxiety-like behaviors, increased heart rate, and neuronal activation in key panic pathways, including subregions of the central nucleus of the amygdala, bed nucleus of the stria terminalis, periaqueductal gray and in the rostroventrolateral medulla. Conclusion: Overall, the data here suggest that the ORX neurons in the DMH/PeF region are critical to eliciting coordinated panic responses and that ORX1 receptor antagonists constitute a potential novel treatment strategy for panic and related anxiety disorders. The neural pathways through which ORX1 receptor antagonists attenuate panic responses involve the extended amygdala, periaqueductal gray, and medullary autonomic centers.

Original languageEnglish
Pages (from-to)733-742
Number of pages10
JournalPhysiology and Behavior
Volume107
Issue number5
DOIs
StatePublished - Dec 5 2012

Fingerprint

Orexin Receptors
Panic
Brain
Dimenhydrinate
Periaqueductal Gray
Anxiety
Panic Disorder
Appetitive Behavior
Pharmaceutical Preparations
Lateral Hypothalamic Area
Purinergic P1 Receptor Antagonists
Neurons
Neural Pathways
Septal Nuclei
Injections
Wakefulness
GABA-A Receptors
Caffeine
Arousal
Amygdala

Keywords

  • Amygdala
  • Anxiety
  • Bed nucleus of the stria terminalus
  • Benzodiazepine
  • BNST
  • FG-7142
  • GABA
  • Hypocretin
  • Hypothalamus
  • Orexin
  • Panic
  • Periaqueductal gray
  • Rostroventrolateral medulla

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Experimental and Cognitive Psychology
  • Philosophy

Cite this

Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. / Johnson, Philip; Samuels, Brian C.; Fitz, Stephanie D.; Federici, Lauren M.; Hammes, Nathan; Early, Maureen C.; Truitt, William; Lowry, Christopher A.; Shekhar, Anantha.

In: Physiology and Behavior, Vol. 107, No. 5, 05.12.2012, p. 733-742.

Research output: Contribution to journalArticle

Johnson, Philip ; Samuels, Brian C. ; Fitz, Stephanie D. ; Federici, Lauren M. ; Hammes, Nathan ; Early, Maureen C. ; Truitt, William ; Lowry, Christopher A. ; Shekhar, Anantha. / Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. In: Physiology and Behavior. 2012 ; Vol. 107, No. 5. pp. 733-742.
@article{280529def0874df084a3c0bbfc509f5f,
title = "Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network",
abstract = "Background: Although the hypothalamic orexin system is known to regulate appetitive behaviors and promote wakefulness and arousal (Sakurai, 2007 [56]), this system may also be important in adaptive and pathological anxiety/stress responses (Suzuki et al., 2005 [4]). In a recent study, we demonstrated that CSF orexin levels were significantly higher in patients experiencing panic attacks compared to non-panicking depressed subjects (Johnson et al., 2010 [9]). Furthermore, genetically silencing orexin synthesis or blocking orexin 1 receptors attenuated lactate-induced panic in an animal model of panic disorder. Therefore, in the present study, we tested if orexin (ORX) modulates panic responses and brain pathways activated by two different panicogenic drugs. Methods: We conducted a series of pharmacological, behavioral, physiological and immunohistochemical experiments to study the modulation by the orexinergic inputs of anxiety behaviors, autonomic responses, and activation of brain pathways elicited by systemic injections of anxiogenic/panicogenic drugs in rats. Results: We show that systemic injections of two different anxiogenic/panicogenic drugs (FG-7142, an inverse agonist at the benzodiazepine site of the GABAA receptor, and caffeine, a nonselective competitive adenosine receptor antagonist) increased c-Fos induction in a specific subset of orexin neurons located in the dorsomedial/perifornical (DMH/PeF) but not the lateral hypothalamus. Pretreating rats with an orexin 1 receptor antagonist attenuated the FG-7142-induced anxiety-like behaviors, increased heart rate, and neuronal activation in key panic pathways, including subregions of the central nucleus of the amygdala, bed nucleus of the stria terminalis, periaqueductal gray and in the rostroventrolateral medulla. Conclusion: Overall, the data here suggest that the ORX neurons in the DMH/PeF region are critical to eliciting coordinated panic responses and that ORX1 receptor antagonists constitute a potential novel treatment strategy for panic and related anxiety disorders. The neural pathways through which ORX1 receptor antagonists attenuate panic responses involve the extended amygdala, periaqueductal gray, and medullary autonomic centers.",
keywords = "Amygdala, Anxiety, Bed nucleus of the stria terminalus, Benzodiazepine, BNST, FG-7142, GABA, Hypocretin, Hypothalamus, Orexin, Panic, Periaqueductal gray, Rostroventrolateral medulla",
author = "Philip Johnson and Samuels, {Brian C.} and Fitz, {Stephanie D.} and Federici, {Lauren M.} and Nathan Hammes and Early, {Maureen C.} and William Truitt and Lowry, {Christopher A.} and Anantha Shekhar",
year = "2012",
month = "12",
day = "5",
doi = "10.1016/j.physbeh.2012.04.016",
language = "English",
volume = "107",
pages = "733--742",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network

AU - Johnson, Philip

AU - Samuels, Brian C.

AU - Fitz, Stephanie D.

AU - Federici, Lauren M.

AU - Hammes, Nathan

AU - Early, Maureen C.

AU - Truitt, William

AU - Lowry, Christopher A.

AU - Shekhar, Anantha

PY - 2012/12/5

Y1 - 2012/12/5

N2 - Background: Although the hypothalamic orexin system is known to regulate appetitive behaviors and promote wakefulness and arousal (Sakurai, 2007 [56]), this system may also be important in adaptive and pathological anxiety/stress responses (Suzuki et al., 2005 [4]). In a recent study, we demonstrated that CSF orexin levels were significantly higher in patients experiencing panic attacks compared to non-panicking depressed subjects (Johnson et al., 2010 [9]). Furthermore, genetically silencing orexin synthesis or blocking orexin 1 receptors attenuated lactate-induced panic in an animal model of panic disorder. Therefore, in the present study, we tested if orexin (ORX) modulates panic responses and brain pathways activated by two different panicogenic drugs. Methods: We conducted a series of pharmacological, behavioral, physiological and immunohistochemical experiments to study the modulation by the orexinergic inputs of anxiety behaviors, autonomic responses, and activation of brain pathways elicited by systemic injections of anxiogenic/panicogenic drugs in rats. Results: We show that systemic injections of two different anxiogenic/panicogenic drugs (FG-7142, an inverse agonist at the benzodiazepine site of the GABAA receptor, and caffeine, a nonselective competitive adenosine receptor antagonist) increased c-Fos induction in a specific subset of orexin neurons located in the dorsomedial/perifornical (DMH/PeF) but not the lateral hypothalamus. Pretreating rats with an orexin 1 receptor antagonist attenuated the FG-7142-induced anxiety-like behaviors, increased heart rate, and neuronal activation in key panic pathways, including subregions of the central nucleus of the amygdala, bed nucleus of the stria terminalis, periaqueductal gray and in the rostroventrolateral medulla. Conclusion: Overall, the data here suggest that the ORX neurons in the DMH/PeF region are critical to eliciting coordinated panic responses and that ORX1 receptor antagonists constitute a potential novel treatment strategy for panic and related anxiety disorders. The neural pathways through which ORX1 receptor antagonists attenuate panic responses involve the extended amygdala, periaqueductal gray, and medullary autonomic centers.

AB - Background: Although the hypothalamic orexin system is known to regulate appetitive behaviors and promote wakefulness and arousal (Sakurai, 2007 [56]), this system may also be important in adaptive and pathological anxiety/stress responses (Suzuki et al., 2005 [4]). In a recent study, we demonstrated that CSF orexin levels were significantly higher in patients experiencing panic attacks compared to non-panicking depressed subjects (Johnson et al., 2010 [9]). Furthermore, genetically silencing orexin synthesis or blocking orexin 1 receptors attenuated lactate-induced panic in an animal model of panic disorder. Therefore, in the present study, we tested if orexin (ORX) modulates panic responses and brain pathways activated by two different panicogenic drugs. Methods: We conducted a series of pharmacological, behavioral, physiological and immunohistochemical experiments to study the modulation by the orexinergic inputs of anxiety behaviors, autonomic responses, and activation of brain pathways elicited by systemic injections of anxiogenic/panicogenic drugs in rats. Results: We show that systemic injections of two different anxiogenic/panicogenic drugs (FG-7142, an inverse agonist at the benzodiazepine site of the GABAA receptor, and caffeine, a nonselective competitive adenosine receptor antagonist) increased c-Fos induction in a specific subset of orexin neurons located in the dorsomedial/perifornical (DMH/PeF) but not the lateral hypothalamus. Pretreating rats with an orexin 1 receptor antagonist attenuated the FG-7142-induced anxiety-like behaviors, increased heart rate, and neuronal activation in key panic pathways, including subregions of the central nucleus of the amygdala, bed nucleus of the stria terminalis, periaqueductal gray and in the rostroventrolateral medulla. Conclusion: Overall, the data here suggest that the ORX neurons in the DMH/PeF region are critical to eliciting coordinated panic responses and that ORX1 receptor antagonists constitute a potential novel treatment strategy for panic and related anxiety disorders. The neural pathways through which ORX1 receptor antagonists attenuate panic responses involve the extended amygdala, periaqueductal gray, and medullary autonomic centers.

KW - Amygdala

KW - Anxiety

KW - Bed nucleus of the stria terminalus

KW - Benzodiazepine

KW - BNST

KW - FG-7142

KW - GABA

KW - Hypocretin

KW - Hypothalamus

KW - Orexin

KW - Panic

KW - Periaqueductal gray

KW - Rostroventrolateral medulla

UR - http://www.scopus.com/inward/record.url?scp=84870689509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870689509&partnerID=8YFLogxK

U2 - 10.1016/j.physbeh.2012.04.016

DO - 10.1016/j.physbeh.2012.04.016

M3 - Article

VL - 107

SP - 733

EP - 742

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 5

ER -